Chapter 3 : Microbial Pathogenic Factors: Small-Colony Variants

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Microbial Pathogenic Factors: Small-Colony Variants, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818067/9781555811778_Chap03-1.gif /docserver/preview/fulltext/10.1128/9781555818067/9781555811778_Chap03-2.gif


A variant subpopulation of has been characterized that is defective in electron transport. These organisms grow slowly and are typical of the small-colony variants (SCVs), which were found to be defective in respiratory activity. Recent work has shown that most of the clinical isolates have inactive electron transport because of biosynthetic defects in the pathways leading to the synthesis of electron transport chain components. The changes in membrane potential and ATP also suggest that electron transport is decreased in both SCVs and adherent bacteria. SCVs from a variety of genera and species have most frequently been isolated from patients and animals treated with antibiotics, especially aminoglycosides, but also sulfonamides and β-lactam antibiotics. The host environment may favor the selection of staphylococcal SVCs. The basis for the persistent and antibiotic resistant infections may be related to the ability of SCVs to reside within cultured cells. Pigment formation and aminoglycoside transport require ATP and an intact electron transport system. The yellow carotenoid pigments that give SCV colonies their characteristic color require ATP for their biosynthesis. Menadione and hemin are the two most frequent substances that reverse the SCV phenotype. In addition, thiamine is a co-factor used in menadione biosynthesis and CO may be involved in the synthesis of the porphyrin ring found in hemin.

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3

Key Concept Ranking

Electron Transport System
Cell Wall Biosynthesis
Transmission Electron Microscopy
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Clinical SCVs are often auxotrophic for menadione or hemin. These variants have defects in either menadione or hemin biosynthesis, making their electron transport chain inactive because they cannot synthesize menaquinone or the hemin portion of cytochromes. The organisms may also be auxotrophic for thiamine since this is a co-factor needed for menadione biosynthesis. Similarly, defects in cytochrome protein biosynthesis also give the SCV phenotype ( ). The F0F1 ATPase is a group of five proteins spanning the membrane that synthesizes ATP and creates an electrochemical gradient by using electrons transferred from the cytochromes. When large amounts of ATP are not available, cell wall biosynthesis slows, which results in small colonies. Decreases in the large electrochemical gradient cause reduced pigment biosynthesis and binding/transport of cationic compounds into staphylococci, leading to nonpigmented colonies that are more resistant to some antibiotics. Finally, interruption of electron transport is postulated to stimulate the production of negative regulators since SCVs show greatly decreased production of toxins. Therefore, interruption of electron transport can account for all of the phenotypic changes seen in SCVs.

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Transmission electron micrograph of a menadione auxotrophic SCV, JB-1 (6). The organism was grown on tryptic soy broth, a low menadione-containing medium, and then incubated for 3.5 h at 35°C with bovine endothelial cells (6). Extracellular JB-1 cells were destroyed by addition of lysostaphin. After 18 h of further incubation, the endothelial monolayer was again treated with lysostaphin and washed and then prepared for transmission electron microscopy. Organisms with the endothelial cell are highlighted with arrows. Of note, the cellular architecture of the endothelial cell is very well preserved, as evidenced by intact mitochondria, philopodia, and other cytoplasmic structures, thus suggesting that the SCVs are causing minimal disruption to this mammalian cell.

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

(A) A hemin auxotrophic SCV, S. aureus PvL-3, is shown on the left side of this tryptic soy agar plate. This disc contains 1 µg of hemin/ml, which is sufficient to relieve the auxotrophy and allow the SCV to grow normally. The parent strain, 6850, is shown on the right half of the plate. The organisms were grown on tryptic soy agar and incubated for 36 h at 35°C. PvL-3 was selected by exposing the parent strain to 1 µg of gentamicin/ml for 3 days in tryptic soy broth (6). (B) A menadione auxotrophic SCV, JB-1, growing rapidly around a piece of filter paper that was supplemented with 1 µg of menadione/ml. In each case, the supplementation allows for rapid growth of the organism (large colonies that are pigmented).

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Acar, J. F.,, F. N. Goldstein,, and P. Lagrange. 1978. Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J. Clin. Microbiol. 8:142147.
2. Arizono, T.,, M. Oga,, and Y. Sugioka. 1992. Increased resistance of bacteria after adherence to polymethyl methacrylate. An in vitro study. Acta Orthop. Scand. 63:661664.
3. Baddour, L. M.,, G. D. Christensen,, J. H. Lowrance,, and W. A. Simpson. 1989. Pathogenesis of experimental endocarditis. Rev. Infect. Dis. 11:452463.
4. Baddour, L. M.,, W. A. Simpson,, J. J. Weems, Jr.,, M. M. Hill,, and G. D. Christensen. 1988. Phenotypic selection of small-colony variant forms of Staphylococcus epidermidis in the rat model of endocarditis. J. Infect. Dis. 157:757763.
5. Baddour Balwit, J. M. 1992. Intracellular persistence of a Staphylococcus aureus small-colony variant. M.S. thesis. University of Wisconsin, Madison.
6. Balwit, J. M.,, P. van Langevelde,, J. M. Vann,, and R. A. Proctor. 1994. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 170: 10331037.
7. Barbour, R. G. H. 1950. Small colony variants (“G” forms) produced by Staphylococcus pyogenes during the development of resistance to streptomycin. Aust. J. Exp. Biol. Med. Sci. 28:411420.
8. Bayer, A. S.,, D. C. Norman,, and K. S. Kim. 1987. Characterization of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocarditis. Antimicrob. Agents Chemother. 31:7075.
9. Bentley, R.,, and R. Meganathan. 1982. Biosynthesis of vitamin K (menaquinone) in bacteria. Microb. Rev. 46:241280.
10. Bisno, A. L., 1989. Infections of central nervous system shunts, p. 93109. In A. L. Bisno, and F. A. Waldvogel (ed.), Infections Associated with Indwelling Medical Devices, 1st ed. American Society for Microbiology, Washington, D.C.
11. Borderon, E.,, and T. Horodniceanu. 1976. Mutants deficients a colonies naines de Staphylococcus: etude de trois souches isolees chez des malades porteurs d'osteosyntheses. Ann. Micro. Inst. Pasteur. 127A: 503514.
12. Borgna-Pignatti, C.,, P. Marradi,, L. Pinelli,, N. Monetti,, and C. Patrini. 1989. Thiamine-responsive anemia in DIDMOAD syndrome. J. Pediatr. 114:405410.
13. Brown, M. R.,, P. J. Collier,, and P. Gilbert. 1990. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob. Agents Chemother. 34:16231628.
14. Browning, C. H.,, and H. S. Adamson. 1950. Stable dwarf-colony forms produced by Staphylococcus pyogenes. J. Pathol. Bacterial. 62:499500.
15. Bryan, L. E.,, and H. M. van den Elzen. 1977. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob. Agents Chemother. 12:163177.
16. Bryan, L. E.,, and S. Kwan. 1981. Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrate reductase, and aerobic transport. Antimicrob. Agents Chemother. 19:958964.
17. Bulger, R. J. 1967. A methicillin-resistant strain of Staphylococcus aureus. Clinical and laboratory experience. Ann. Intern. Med. 67:8189.
18. Chambers, H. F.,, and M. M. Miller. 1987. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J. Infect Dis. 155:581585.
19. Chin, Y. M.,, and S. A. Harmon. 1971. Genetic studies of kanamycin resistance in Staphylococcus aureus. Jpn. J. Microbiol. 15:417423.
20. Chinn, B. D. 1936. Characteristics of small colony variants with special reference to Shigella paradysenteriae sonne. J. Infect. Dis. 59:137151.
21. Chinn, B. D. 1936. Characteristics of small colony variants of Shigella paradysenteriae sonne. and Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 34:237238.
22. Chuard, C.,, M. Herrmann,, P. Vaudaux,, F. A. Waldvogel,, and D. P. Lew. 1991. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob. Agents Chemother. 35:26112616.
23. Chuard, C.,, P. E. Vaudaux,, R. A. Proctor,, and D. P. Lew. 1997. Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J. Antimicrob. Chemother. 39:603608.
24. Chuard, C.,, P. Vaudaux,, F. A. Waldvogel,, and D. P. Lew. 1993. Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob. Agents Chemother. 37: 625632.
24a. Clements, M. O.,, S. P. Watson,, R. K. Poole,, and S. J. Foster. 1999. CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis. J. Bacteriol. 181:501507.
25. Colien, E. E. 1935. A study of microbic variation in a yellow pigment-producing coccus. J. Bacteriol. 30:301321.
26. Colwell, C. A. 1946. Small colony variants of Escherichia coli. J. Bacteriol. 52:417422.
27. Devriese, L. A. 1973. Hemin-dependent mutants isolated from methicillin-resistant Staphylococcus aureus strains. Antonie Van Leeuwenhoek. J. Microbiol. Serol. 39:3340.
28. Dietz, A. S.,, L. I. Albright,, T. Tuominen. 1976. Heterotrophic activities of bacterioneuston and bacteri-oplankton. Can. J. Microbiol. 22:16991709.
29. Dworkin, R.,, G. Modin,, S. Kunz,, O. Rich,, O. Zak,, and M. Sande. 1990. Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis. Antimicrob. Agents Chemother. 34:10141016.
30. Evans, D. J.,, D. G. Allison,, M. R. W. Brown,, and P. Gilbert. 1991. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms toward ciprofloxacin: effect of specific growth rate. J. Antimicrob. Chemother. 27:177184.
31. Fujiswara, S.,, Y. Miyake,, T. Usui,, and H. Suginaka. 1998. Effect of adherence on antimicrobial susceptibility of Pseudomonas aeruginosa, Serratia marcescens, and Proteus mirabilis. Hiroshima J. Med. Sci. 47:15.
32. Goudie, J. G.,, and R. B. Goudie. 1955. Recurrent infection by a stable dwarf-colony variant of Staphylococcus aureus. J. Clin. Pathol. 8:284287.
33. Hadley, P.,, and H. Carapetian. 1933. A study of the infective qualities possessed by G phase pleomorphism and filterability. J. Bacteriol. 25:9496.
34. Hale, J. H. 1947. Studies on staphylococcal mutation: characterization of the "G" (gonidial) variant and factors concerned in its production. Br. J. Exp. Pathol. 28:202210.
35. Hale, J. H. 1951. Studies on Staphylococcus mutation: a naturally occurring "G" gonidial variant and its carbon dioxide requirements. Br. J. Exp. Pathol. 32:307313.
36. Haung, C. T.,, F. P. Yu,, G. A. McFeters,, and P. S. Stewart. 1995. Nonuniform spatial patterns of respiratory activity within biofilms during disinfection. Appl. Environ. Microbiol. 61:22522256.
37. Henry, N. K.,, M. S. Rouse,, A. L. Whitesell,, M. E. McConnell,, and W. R. Wilson. 1987. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. Am. J. Med. 82(Suppl. 4A):7375.
38. Hoffstadt, R. E.,, and G. P. Youmans. 1932. Staphylococcus aureus: dissociation and its relation to infection and to immunity. J. Infect. Dis. 51:216242.
39. Huddleson, I. F.,, and B. Baltzer. 1952. The characteristics and dissociation pattern of type G (micro-colony type) of Brucella arbortus, p. 6483. In Studies in Brucellosis III. A series of five papers. Dep. Bacteriol. Public Health, Agric. Exp. Station, Michigan State College, East Lansing, Mich.
40. Jensen, J. 1957. Biosynthesis of hematin compounds in a hemin requiring strain of Micrococcus pyogenes var. aureus. J. Bacteriol. 73:324333.
41. Joyce, G. H.,, and D. C. White. 1971. Effects of benso(a)pyrene and piperonyl butoxide on formation of respiratory system, phospholipids, and carotenoids of Staphylococcus aureus. J. Bacteriol. 106:403411.
42. Kahl, B.,, R. A. Proctor,, and G. Peters. 1996. Staphylococcal small colony variants present a challenge to clinicians and clinical microbiologists. Antimicrob. Infect. Dis. News 15:5963.
43. Kahl, B.,, R. A. Proctor,, A. Schulze-Everding,, M. Herrmann,, H. G. Koch,, I. Harms,, and G. Peters. 1998. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177:10231029.
44. Kaplan, M. L.,, and W. E. Dye. 1976. Growth requirements of some small-colony-forming variants of Staphylococcus aureus. J. Clin. Microbiol. 4:343348.
45. Kolle, W.,, and H. Hetsch. 1911. Die experimented Bacteriologie und die Infectionskrankheiten mit besonderer Bertticksichtigung der Immunitdtslehre, vol. 1. 3rd ed. Urban und Schwarzenberg, Berlin, Germany.
46. Koneman, E. W.,, S. D. Allen,, V. R. Dowell, Jr.,, and H. M. Sommers. 1979. Color Atlas and Textbook of Diagnostic Microbiology, 2nd ed., p. 264265. J. B. Lippincott, Philadelphia, Pa.
47. Koo, S.-P.,, A. S. Bayer,, H.-G. Sahl,, R. A. Proctor,, and M. R. Yeaman. 1996. Staphylocidal action of thrombin-induced platelet microbicidal protein (tPMP) is not solely dependent on transmembrane potential (A*). Infect. Immun. 64:10701074.
48. Kopeleff, N. 1934. Dissociation and filtration of Lactobacillus acidophilus. J. Infect. Dis. 55:368389.
49. Kullik, I.,, P. Giachino,, and T. Fuchs. 1998. Deletion of the alternative sigma factor, sigmaB, in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180:48144820.
50. Lacy, R. W. 1969. Dwarf-colony variants of Staphylococcus aureus resistant to aminoglycoside antibiotics and to a fatty acid. J. Med. Microbiol. 2:187197.
51. Lacy, R. W.,, and A. A. B. Mitchell. 1969. Gentamicin-resistant Staphylococcus aureus. Lancet ii: 14251426.
52. Lewis, L. A.,, K. Li,, M. Bharosay,, M. Cannella,, V. Jorgenson,, R. Thomas,, D. Pena,, M. Velez,, B. Pereira,, and A. Sassine. 1990. Characterization of gentamicin-resistant respiratory-deficient (Res-) variant strains of Staphylococcus aureus. Microbiol. Immunol. 34:587605.
53. Li, K.,, J. J. Fanner III,, and A. Coppola. 1974. A novel type of resistant bacteria induced by gentamicin. Trans. N.Y. Acad. Sci. 36:396415.
54. McCabe, K.,, M. D. Mann,, and M. D. Bowie. 1998. D-Lactate production and [14C] succinic acid uptake by adherent and nonadherent Escherichia coli. Infect. Immun. 66:907911.
55. Miller, M. H.,, S. C. Edberg,, L. J. Mandel,, F. C. Behar,, and N. H. Steigbigel. 1980. Gentamicin uptake in wild type and aminoglycoside-resistant small colony mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 18:722729.
56. Miller, M. H.,, M. A. Wexler,, and N. H. Steigbigel. 1978. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin mutants. Antimicrob. Agents Chemother. 14:336343.
57. Morton, H. E.,, and J. Shoemaker. 1945. The identification of Neisseria gonorrhoeae by means of bacterial variation and the detection of small colony forms in clinical material. J. Bacteriol. 50:585590.
58. Musher, D. M.,, R. E. Baughn,, G. B. Templeton,, and J. N. Minuth. 1977. Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J. Infect. Dis. 136:360369.
59. Nydahl, B. C, and W. L. Hall. 1965. The treatment of staphylococcal infection with nafcillin with a discussion of staphylococcal nephritis. Ann. Intern. Med. 63:2743.
60. Padmanaban, G.,, V. Venkateswar,, and P. N. Rangarajan. 1989. Haem as a multifunctional regulator. Trends Biochem. Sci. 14:492496.
61. Pelletier, L. L., Jr.,, M. Richardson,, and M. Feist. 1979. Virulent gentamicin-induced small colony variants of Staphylococcus aureus. J. Lab. Clin. Med. 94:324334.
62. Proctor, R. A. 1998. Bacterial energetics and antimicrobial resistance. Drug Resist. Updates 1:227235.
63. Proctor, R. A., 2000. Respiration and small-colony variants of Staphylococcus aureus, p. 345350. In V. A. Fischetti,, R. P. Novick,, J. J. Ferretti,, D. A. Portnoy,, and J. I. Rood (ed.), Gram-Positive Pathogens. ASM Press, Washington, D.C.
64. Proctor, R. A. J. M. Balwit,, and O. Vesga. 1994. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect. Agents Dis. 3:302312.
65. Proctor, R. A.,, and G. Peters. 1998. Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin. Infect. Dis. 27:419423.
66. Proctor, R. A.,, B. Kahl,, C. von Eiff,, P. E. Vaudaux,, D. P. Lew,, and G. Peters. 1998. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin. Infect. Dis. 27(Suppl. 1):S68S74.
67. Proctor, R. A.,, P. van Langevelde,, M. Kristjansson,, J. N. Maslow,, and R. D. Arbeit. 1995. Persistent and relapsing infections associated with small colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20:95102.
68. Proctor,, R. A. O. Vesga,, M. F., Otten,, S.-P. Koo,, M. R. Yeaman,, H.-G. Sahl,, and A. S. Bayer. 1996. Staphylococcus aureus small colony variants cause persistent and resistant infections. Chemotherapy 42(Suppl. 2):4752.
69. Quie, P. G. 1969. Microcolonies (G variants) of Staphylococcus aureus. Yale J. Biol. Med. 41:394403.
70. Sasarman, A.,, K. E. Sanderson,, M. Surdeanu,, and S. Sonea. 1970. Hemin-deficient mutants of Salmonella typhimurium. J. Bacteriol. 102:531536.
71. Sasarman, A.,, M. Surdeanu,, V. Portelance,, R. Dobardzic,, and S. Sorrea. 1971. Classification of vitamin K-deficient mutants of Staphylococcus aureus. J. Gen. Microbiol. 65:125130.
72. Sasarman, A.,, M. Surdeanu,, J. Sabados,, V. Greceanu,, and T. Horodniceanu. 1968. Menaphthone requiring mutants of Staphylococcus aureus. Rev. Can. Biol. 23:333340.
73. Sasarman, A.,, and T. Horodniceanu. 1967. Locus determining normal colony formation on the chromosome of Escherichia coli K12. J. Bacteriol. 94:12681269.
74. Schierholz, J. M.,, J. Beuth,, and B. Pulverer. 1999. Adherent bacteria and activity of antibiotics. J. Antimicrob. Chemother. 43:158160.
75. Schnitzer, R. J.,, L. J. Canagni,, and M. Back. 1943. Resistance of small colony variants (G forms) of a Staphylococcus toward the bacteriostatic activity of penicillin. Proc. Soc. Exp. Biol. Med. 53:7578.
76. Schwank, S.,, A. Rajacic,, W. Zimmerli,, and J. Blaser. 1998. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob. Agents Chemother. 42:895898.
77. Seifert, H.,, C. von Eiff,, and G. Fätkenheuer. 1999. Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg. Infect. Dis. 5:450452.
78. Shearer, M. J.,, P. T. McCarthy,, O. E. Crampton,, and M. B. Mattock,. 1987. The assessment of human vitamin K status from tissue measurements, p. 437452. In J. W. Suttie (ed.), Current Advances in Vitamin K Research. Elsevier, New York, N.Y.
79. Sherris, J. C. 1952. Two small colony variants of Staphylococcus aureus isolated in pure culture from closed infected lesions and their carbon dioxide requirements. J. Clin. Pathol. 5:354355.
80. Short, S. A.,, D. C. White,, and H. R. Kaback. 1972. Active transport in isolated bacterial membrane vesicles. V. The transport of amino acids by membrane vesicles prepared from Staphylococcus aureus. J. Biol. Chem. 247:298304.
81. Slifkin, M.,, L. P. Merkow,, S. A. Kreuzberger,, C. Engwall,, and M. Pardo. 1971. Characterization of CO2 dependent microcolony variants of Staphylococcus aureus. Am. J. Clin. Pathol. 56:584592.
82. Sompolinsky, D.,, M. Cohen,, and G. Ziv. 1974. Epidemiological studies on thiamine-less dwarf-colony variants of Staphylococcus aureus as etiologic agents of bovine mastitis. Infect. Immun. 9:217228.
83. Sompolinsky, D.,, Z. E. Geller,, and S. Segal. 1967. Metabolic disorders in thiamine-less dwarf strains of Staphylococcus aureus. J. Gen. Microbiol. 48:205213.
84. Spagna, V. A.,, R. J. Fass,, R. B. Prior,, and T. G. Slama. 1978. Report of a case of bacterial sepsis caused by a naturally occurring variant form of Staphylococcus aureus. J. Infect. Dis. 138:277278.
85. Swingle, E. L. 1934. Studies on small colony variants of Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 31:891893.
86. Swingle, E. L. 1935. Studies on a small colony variant of Staphylococcus aureus. J. Bacteriol. 29:467490.
87. Thomas, M. E. M.,, and J. H. Cowlard. 1955. Studies on a C02-dependent Staphylococcus. J. Clin. Pathol. 8:288291.
88. Tien, W.,, and D. C. White. 1968. Linear sequential arrangement of genes for the biosynthetic pathway of protoheme in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 61:13921398.
89. Vann, J. M.,, and R. A. Proctor. 1988. Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus a-hemolysin. Microb. Pathog. 4:443453.
90. Vergeres, P.,, and J. Blaser. 1992. Amikacin, ceftazidime, and flucloxacillin against suspended and adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an in vitro model of infection. J. Infect. Dis. 165:281289.
91. Vesga, O.,, M. C. Groeschel,, M. F. Otten,, D. W. Brar,, J. M. Vann,, and R. A. Proctor. 1996. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J. Infect. Dis. 173:739742.
92. von Eiff, C.,, D. Bettin,, R. A. Proctor,, B. Rolauffs,, N. Lindner,, W. Winkelmann,, and G. Peters. 1997. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin. Infect. Dis. 25:12501251.
93. von Eiff, C.,, C. Heilmann,, R. A. Proctor,, C. Woltz,, G. Peters,, and F. Gotz. 1997. A site directed Staphylococcus aureus hemB mutant is a small colony variant which persists intracellularly. J. Bacteriol. 179:47064712.
94. von Eiff, C.,, N. Lindner,, R. A. Proctor,, W. Winkelmann,, and G. Peters. 1998. Isolation of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis as a possible cause for recurrence. Z. Orthop. 136:268271.
95. von Eiff, C.,, P. Vaudaux,, B. Kahl,, D. P. Lew,, S. Emler,, A. Schmidt,, G. Peters, and R. A. Proctor. 1999. Bloodstream infections caused by small-colony variants of coagulase negative staphylococci following pacemaker placements. Clin. Infect. Dis. 29:932934.
96. Weinberg, E. D. 1950. Vitamin requirements of dwarf colony variants of bacteria. J. Infect. Dis. 87: 299306.
97. Widmer, A. F.,, A. Wiestner,, R. Frei,, and W. Zimmerli. 1991. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob. Agents Chemother. 35: 741746.
98. Wilson, S. G.,, and C. C. Sanders. 1976. Selection and characterization of strains of Staphylococcus aureus displaying unusual resistance to aminoglycosides. Antimicrob. Agents Chemother. 10:519525.
99. Wise, R. 1.1956. Small colonies (G variants) of staphylococci: isolation from cultures and infections. Ann. N.Y. Acad. Sci. 65:169174.
100. Wise, R. I.,, and W. W. Spink. 1954. The influence of antibiotics on the origin of small colony (G variants) of Micrococcus pyogenes var. aureus. J. Clin. Invest. 33:16111622.
101. Yegian, D.,, G. Gallo,, and M. W. Toll. 1959. Kanamycin resistant staphylococcus mutants requiring hemin for growth. J. Bacteriol. 78:1012.
102. Youmans, G. P. 1937. Production of small colony variants of Staphylococcus aureus. Proc. Soc. Exp. Biol. Med. 36:9498.
103. Youmans, G. P.,, and E. Delves. 1942. The effect of inorganic salts on the production of small colony variants by Staphylococcus aureus. J. Bacteriol. 44:127136.
104. Youmans, G. P.,, E. H. Williston,, and M. Simon. 1945. Production of small colony variants of Staphylococcus aureus by the action of penicillin. Proc. Soc. Exp. Biol. Med. 58:5657.
105. Yu, F. P.,, and G. A. McFeters. 1994. Physiological responses of bacteria in biofilms to disinfection. Appl. Environ. Microbiol. 60:24622466.


Generic image for table
Table 1

Comparison of SCVs and adherent bacteria

Citation: Proctor R. 2000. Microbial Pathogenic Factors: Small-Colony Variants, p 41-54. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch3

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error